BR0313665A - Utilização de bupropion para o tratamento da sìndrome das pernas inquietas - Google Patents

Utilização de bupropion para o tratamento da sìndrome das pernas inquietas

Info

Publication number
BR0313665A
BR0313665A BR0313665-5A BR0313665A BR0313665A BR 0313665 A BR0313665 A BR 0313665A BR 0313665 A BR0313665 A BR 0313665A BR 0313665 A BR0313665 A BR 0313665A
Authority
BR
Brazil
Prior art keywords
bupropion
treatment
restless leg
leg syndrome
syndrome
Prior art date
Application number
BR0313665-5A
Other languages
English (en)
Inventor
David Wayne Robertson
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of BR0313665A publication Critical patent/BR0313665A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Structure Of Belt Conveyors (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"UTILIZAçãO DE BUPROPION PARA O TRATAMENTO DA SìNDROME DAS PERNAS INQUIETAS". A presente invenção fornece a utilização de bupropion ou um sal farmaceuticamente aceitável deste no tratamento da síndrome de pernas inquietas em seres humanos.
BR0313665-5A 2002-08-26 2003-08-22 Utilização de bupropion para o tratamento da sìndrome das pernas inquietas BR0313665A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40594302P 2002-08-26 2002-08-26
PCT/US2003/024795 WO2004017951A1 (en) 2002-08-26 2003-08-22 Use of bupropion for the manufacture of a medicament for treating restless legs syndrome

Publications (1)

Publication Number Publication Date
BR0313665A true BR0313665A (pt) 2005-06-14

Family

ID=31946948

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0313665-5A BR0313665A (pt) 2002-08-26 2003-08-22 Utilização de bupropion para o tratamento da sìndrome das pernas inquietas

Country Status (8)

Country Link
US (1) US20040115263A1 (pt)
EP (1) EP1545486A1 (pt)
JP (1) JP2005538147A (pt)
AU (1) AU2003261459A1 (pt)
BR (1) BR0313665A (pt)
CA (1) CA2494658A1 (pt)
MX (1) MXPA05001557A (pt)
WO (1) WO2004017951A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1899A (en) * 2003-08-08 2008-10-10 Biovail Lab Int Srl Modified-release tablet of bupropion hydrochloride
EP2502621A1 (en) * 2005-06-27 2012-09-26 Valeant International (Barbados) SRL Crystalline forms of bupropion HBr
WO2008077127A2 (en) * 2006-12-19 2008-06-26 Lavin Thomas N Use of modafinil to treat restless leg syndrome
ES2447295T3 (es) 2009-11-06 2014-03-11 Sk Biopharmaceuticals Co., Ltd. Métodos para el tratamiento del trastorno de déficit de atención/hiperactividad
KR101783633B1 (ko) 2009-11-06 2017-10-10 에스케이바이오팜 주식회사 섬유근육통 증후군의 치료 방법
US8623913B2 (en) * 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
AU2013315750B9 (en) 2012-09-11 2018-11-15 Coherus Biosciences, Inc. Correctly folded etanercept in high purity and excellent yield

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030092759A1 (en) * 2001-09-24 2003-05-15 Abuzzahab Faruk S. Anticonvulsant derivatives useful for the treatment of restless limb syndrome and periodic limb movement disorder

Also Published As

Publication number Publication date
JP2005538147A (ja) 2005-12-15
MXPA05001557A (es) 2005-08-19
AU2003261459A1 (en) 2004-03-11
WO2004017951A1 (en) 2004-03-04
EP1545486A1 (en) 2005-06-29
CA2494658A1 (en) 2004-03-04
US20040115263A1 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
BRPI0407662A (pt) derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas
EE02971B1 (et) Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
DOP2002000429A (es) Imidazotriazinas
BR0309099A (pt) Composições farmacêuticas com base em anticolonérgicos e inibidores da p38 cinase
DK1525177T3 (da) Substituerede 1,3-diphenylprop-2-en-1-on-derivater, fremstilling og anvendelse deraf
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
DK0589893T3 (da) Anvendelse af et bakteriocin som antimikrobielt middel til fremstilling af et lægemiddel til behandl ing af maveforstyrrelser forbundet med helicobacter pylori
PT1202722E (pt) Usos para o tratamento ou prevencao de disturbios do sono usando doses muito baixas de ciclobenzaprina
CY1107312T1 (el) Θειικη 3,5,3’-τριιωδοθυρονινη σαν θυρεοειδο-μιμητικος παραγοντας και φαρμακευτικα σκευασματα της
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
BR0313665A (pt) Utilização de bupropion para o tratamento da sìndrome das pernas inquietas
DE50101034D1 (de) Medizinischer oder dentalmedizinischer behandlungsstuhl
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
PT1362590E (pt) Utilizacao de cilobradina ou dos seus sais farmaceuticamente aceitaveis para o tratamento ou prevencao de falha cardiaca
EE200200605A (et) Asendatud akrüloüüldistamütsiini derivaadi kasutamine ravimi valmistamiseks, mis on ette nähtud glutatiooni kõrge tasemega seotud kasvajate raviks
ATE456943T1 (de) Knie-immobilisator
BRPI0412288A (pt) uso de aivlosina para o tratamento, prevenção ou controle de doenças em virtude de brachyspira pilosicoli em porcos e ornithobacterium rhinotracheale em aves
BR0309055A (pt) Uso combinado de l-carnitina, acetil l-carnitina e propionil l-carnitina para o tratamento da oligoastenoteratospermia
CY1109771T1 (el) Η χρηση της φορμοτερολης στην προφυλακτικη και/ή θεραπευτικη αντιμετωπιση της μυικης απωλειας και/ή του καχεκτικου συνδρομου τα οποια συνδεονται με τις καταβολικες συνθηκες ορισμενων παθησεων. οπως ο καρκινος, to aids, οι μολυνσεις, ο διαβητης και αλλες
BRPI0406746A (pt) Preparado de combinação contra tontura
DK1497250T3 (da) Hyperforinderivater, anvendelse heraf og sammensætninger indeholdende disse
CL2004001005A1 (es) Compuestos derivados de macrolidos de 15 miembros, sustituidos en posicion 4", procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topicas.
AR027958A1 (es) Composicion para la prevencion y/o tratamiento de enfermedades vasculares, que comprende propionil l-carnitina y coenzima q10
WO2004006900A3 (en) Sulphydryl compounds in combination with sulphone or sulphnamide conpounds for use in microbial inflammatory diseases

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A,5A,6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2069 DE 31/08/2010.